Skip to main content
SpringerLink
Log in

The Epidemiology of HIV and AIDS

  • Chapter
AIDS in Africa

Conclusion

The impact of HIV-1 on Africa has been devastating, and the number of people already infected with HIV means that its impact will inevitably worsen in coming decades. However, the lessons learned from the successful responses to this problem, which have resulted in sustained reductions in HIV prevalence in some areas, demonstrate that it is possible to reduce the spread of the epidemic and to mitigate its impact. To do so requires comprehensive responses that take account not only of the heterogeneity of the epidemic but the complex social, population, and biologic dynamics that determine the course of the epidemic.

There can be no shortcut substitute for broad social mobilization in responding to HIV. The two-decade-long history of responses to AIDS is already littered with failed attempts to devise one-time, universally applicable, technically driven solutions. Massive rollout of antiretroviral therapy, STD treatment, and male circumcision are merely the latest of these. Despite the intrinsic merits, at least of antiretroviral therapy and STD treatment, these interventions alone will not provide plausible solutions to the crises caused by the spread and impact of HIV in Africa. Even an effective HIV vaccine is unlikely to be universally available and acceptable, or to confer complete sterilizing immunity. For the foreseeable future, the solutions to AIDS will be developed in the complex territory formed at the intersection of politics, science, and mass mobilization. The principal determinant of the future course of the HIV epidemic in Africa will remain African leadership, from village levels and up.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. UNAIDS and WHO. AIDS Epidemic Update December 2001. Geneva, Switzerland: UNAIDS and WHO, 2001.

    Google Scholar 

  2. Piot P, Bartos M, Ghys PD, et al. The global impact of HIV/AIDS. Nature, 2001;410:968–973.

    Article  PubMed  CAS  Google Scholar 

  3. World Health Organization. The World Health Report 2000. Health systems: improving performance. Geneva: World Health Organization, 2000.

    Google Scholar 

  4. Mogae F, Phumaphi HJ, Khan AB, et al. Botswana 2000 HIV Sero-Prevalence Sentinel Survey amongst Pregnant Women and Men with Sexually Transmitted Diseases. Technical Report. National AIDS Coordinating Agency, AIDS/STD Unit, District Health Teams, WHO, CDC, December 2000. Cited in: US Census Bureau HIV/AIDS Surveillance Data Base Summary Tables. Table 3: Detailed Listing of Estimates of HIV-1 & HIV-2 Seroprevalence, by Residence and Risk Factor, for Developing Countries: Circa 2000. Available at: http://www.census.gov/ipc/www/hivtable.html. Accessed 5 February 2002.

  5. HIV/AIDS surveillance data base, June 2000. United States Bureau of the Census, Population Division, International Programs Center. Available at: http://www.census.gov.

  6. Department of Health, Republic of South Africa. National HIV and Syphilis Sero-Prevalence Survey of Women Attending Public Antenatal Clinics in South Africa. Pretoria: Department of Health, 2001.

    Google Scholar 

  7. Ghana Ministry of Health. HIV Sentinel Surveillance 1998. Report. Accra, Ghana: Disease Control Unit, Ministry of Health, July 1999. Cited in US Census Bureau HIV/AIDS Surveillance Data Base Summary Tables. Table 3: Detailed Listing of Estimates of HIV-1 & HIV-2 Seroprevalence, by Residence and Risk Factor, for Developing Countries: Circa 2000. Available at: http://www.census.gov/ipc/www/hivtable.html. Accessed 5 February 2002.

    Google Scholar 

  8. Mingle JA, Asamoah-Adu A, Bekoe V Trends in Human Immunodeficiency Virus (HIV) Infection in Sexually Active Ghanaian Women. Poster at: 12th World AIDS Conference; June 28–July 3, 1998; Geneva, Switzerland. Poster 23593. Cited in US Census Bureau HIV/AIDS Surveillance Data Base Summary Tables. Table 3: Detailed Listing of Estimates of HIV-1 & HIV-2 Seroprevalence, by Residence and Risk Factor, for Developing Countries: Circa 2000. Available at: http://www.census.gov/ipc/www/hivtable.html. Accessed 5 February 2002.

  9. UNAIDS. AIDS in Africa, Country by Country. UNAIDS/00.30E. Geneva, Switzerland: UNAIDS, 2000.

    Google Scholar 

  10. de Vincenzi I. A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. European Study Group on Heterosexual Transmission of HIV N Engl J Med, 1994;331:341–346.

    PubMed  Google Scholar 

  11. Gray RH, Wawer MJ, Brookmeyer R, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet, 2001;357:1149–1153.

    PubMed  CAS  Google Scholar 

  12. Mastro TD, Kitayaporn D. HIV type 1 transmission probabilities: estimates from epidemiological studies. AIDS Res Hum Retroviruses, 1998; 14(Suppl 3):S223–S227.

    PubMed  Google Scholar 

  13. Nicolosi A, Correa Leite ML, Musicco M, et al. The efficiency of male-to-female and female-tomale sexual transmission of the human immunodeficiency virus: a study of 730 stable couples. Italian Study Group on HIV Heterosexual Transmission. Epidemiology, 1994;5:570–575.

    PubMed  CAS  Google Scholar 

  14. Padian NS, Shiboski SC, Jewell NP. Female-tomale transmission of human immunodeficiency virus. JAMA, 1991;266:1664–1667.

    Article  PubMed  CAS  Google Scholar 

  15. Royce RA, Sena A, Cates W, Jr., et al. Sexual transmission of HIV N Engl J Med, 1997;336:1072–1078.

    Article  PubMed  CAS  Google Scholar 

  16. Mayer KH, Anderson DJ. Heterosexual HIV transmission. Infect Agents Dis, 1995;4:273–284.

    PubMed  CAS  Google Scholar 

  17. O’Brien TR, Busch MP, Donegan E, et al. Heterosexual transmission of human immunodeficiency virus type 1 from transfusion recipients to their sex partners. J Acquir Immune Defic Syndr, 1994;7:705–710.

    Google Scholar 

  18. Fideli US, Allen SA, Musonda R, et al. Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. AIDS Res Hum Retroviruses, 2001;17:901–910.

    Article  PubMed  Google Scholar 

  19. Auvert B, Buonamico G, Lagarde E, et al. Sexual behavior, heterosexual transmission, and the spread of HIV in sub-Saharan Africa: a simulation study. Comput Biomed Res, 2000;33:84–96.

    Article  PubMed  CAS  Google Scholar 

  20. Cohen MS. Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis. Lancet, 1998;351(Suppl 3):5–7.

    PubMed  Google Scholar 

  21. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex. Transm Infect, 1999;75:3–17.

    Article  PubMed  CAS  Google Scholar 

  22. Cameron DW, Simonsen JN, D’Costa LJ, et al. Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet, 1989; 2:403–407.

    PubMed  CAS  Google Scholar 

  23. Laga M, Nziia N, Goeman J. The interrelationship of sexually transmitted diseases and HIV infection: implications for the control of both epidemics in Africa. AIDS, 1991:5:555–563.

    Google Scholar 

  24. Mastro TD, Satten GA, Nopkesorn T, et al. Probability of female-to-male transmission of HIV-1 in Thailand. Lancet, 1994;343:204–207.

    Article  PubMed  CAS  Google Scholar 

  25. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med, 2000;342:921–929.

    Article  PubMed  CAS  Google Scholar 

  26. Lee TH, Sakahara N, Fiebig E, et al. Correlation of HIV-1 RNA levels in plasma and heterosexual transmission of HIV-1 from infected transfusion recipients. J Acquir Immune Defic Syndr Hum Retrovirol, 1996;12:427–428.

    PubMed  CAS  Google Scholar 

  27. Operskalski EA, Stram DO, Busch MP, et al. Role of viral load in heterosexual transmission of human immunodeficiency virus type 1 by blood transfusion recipients. Transfusion Safety Study Group. Am J Epidemiol, 1997;146:655–661.

    PubMed  CAS  Google Scholar 

  28. Pedraza MA, del Romero J, Roldan F, et al. Heterosexual transmission of HIV-1 is associated with high plasma viral load levels and a positive viral isolation in the infected partner. J Acquir Immune Defic Syndr, 1999;21:120–125.

    PubMed  CAS  Google Scholar 

  29. Ragni MV, Faruki H, Kingsley LA. Heterosexual HIV-1 transmission and viral load in hemophiliac patients. J Acquir Immune Defic Syndr Hum Retrovirol, 1998;17:42–45.

    PubMed  CAS  Google Scholar 

  30. Laga M, Taelman H, Van der Stuyft P, et al. Advanced immunodeficiency as a risk factor for heterosexual transmission of HIV AIDS, 1989;3:361–366.

    PubMed  CAS  Google Scholar 

  31. Nelson KE, Rungruengthanakit K, Margolick J, et al. High rates of transmission of subtype E human immunodeficiency virus type 1 among heterosexual couples in Northern Thailand: role of sexually transmitted diseases and immune compromise. J Infect Dis, 1999;180:337–343.

    Article  PubMed  CAS  Google Scholar 

  32. Cameron DW, Simonsen JN, D’Costa W, et al. Female to male transmission of human immunodeficiency virus type I: risk factors for seroconversion in men. Lancet, 1989;2:403–407.

    PubMed  CAS  Google Scholar 

  33. Laga M, Manoka A, Kivuvu M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIVI transmission in women: results from a cohort study. AIDS, 1993;7:95–102.

    PubMed  CAS  Google Scholar 

  34. Padian N, Marquis L, Francis DP, et al. Male-to-female transmission of human immunodeficiency virus. JAMA, 1987;258:788–790.

    Article  PubMed  CAS  Google Scholar 

  35. UNAIDS. New Data on the Prevention of Mother-to-Child Transmission of HIV and their Policy Implications. WHO Technical Consultation on Behalf of the UNFPA/UNICEF/WHO/UNAIDS Inter-Agency Task Team on Mother-to-Child Transmission of HIV; October 11–13, 2000; Geneva, Switzerland.

    Google Scholar 

  36. Luo C. Strategies for prevention of mother-to-child transmission of HIV Reprod Health Matters, 2000;8:144–155.

    Article  PubMed  CAS  Google Scholar 

  37. Wiktor SZ, Ekpini E, Nduati RW. Prevention of mother-to-child transmission of HIV-1 in Africa. AIDS, 1997;11(Suppl B):S79–S87.

    PubMed  Google Scholar 

  38. Garcia PM, Kalish LA, Pitt J, et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med, 1999;341:394–402.

    PubMed  CAS  Google Scholar 

  39. McGowan JP, Shah SS. Prevention of perinatal HIV transmission during pregnancy. J Antimicrob Chemother, 2000;46:657–668.

    Article  PubMed  CAS  Google Scholar 

  40. Mock PA, Shaffer N, Bhadrakom C, et al. Maternal viral load and timing of mother-to-child HIV transmission, Bangkok, Thailand. Bangkok Collaborative Perinatal HIV Transmission Study Group. AIDS, 1999;13:407–414.

    Article  PubMed  CAS  Google Scholar 

  41. Mofenson LM, Lambert JS, Stiehm ER, et al. Risk factors for perinatal transmission of human immunodeficiency virus type I in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team. N Engl J Med, 1999;341:385–393.

    Article  PubMed  CAS  Google Scholar 

  42. Shaffer N, Roongpisuthipong A, Siriwasin W, et al. Maternal virus load and perinatal human immunodeficiency virus type 1 subtype E transmission, Thailand. Bangkok Collaborative Perinatal HIV Transmission Study Group. J Infect Dis, 1999;179:590–599.

    Article  PubMed  CAS  Google Scholar 

  43. World Health Organization. New Data on the Prevention of Mother-to-Child Transmission of HIV and their Policy Implications. Geneva: World Health Organization, 2000.

    Google Scholar 

  44. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet, 1999;354:795–802.

    PubMed  CAS  Google Scholar 

  45. Nduati R, John G, Mbori-Ngacha D, et al. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA, 2000;283:1167–1174.

    Article  PubMed  CAS  Google Scholar 

  46. Coutsoudis A, Pillay K, Kuhn L, et al. Method of feeding and transmission of HIV-1 from mothers to children by 15 months of age: prospective cohort study from Durban, South Africa. AIDS, 2001;15:379–387.

    Article  PubMed  CAS  Google Scholar 

  47. Donegan E, Lee H, Operskalski EA, et al. Transfusion transmission of retroviruses: human T-lymphotropic virus types I and II compared with human immunodeficiency virus type 1. Transfusion, 1994;34:478–483.

    Article  PubMed  CAS  Google Scholar 

  48. Greenberg AE, Nguyen-Dinh P, Mann JM, et al. The association between malaria, blood transfusions, and HIV seropositivity in a pediatric population in Kinshasa, Zaire. JAMA, 1988;259:545–549.

    Article  PubMed  CAS  Google Scholar 

  49. Izzia KW, Lepira B, Kayembe K, et al. Acquired immunodeficiency syndrome and homozygote sickle cell anemia. Apropos of a Zairian case. Ann. Soc Belg Med Trop, 1984;64;391–396.

    PubMed  CAS  Google Scholar 

  50. Jacobs B, Mercer A. Feasibility of hospital-based blood banking: a Tanzanian case study. Health Policy Plan, 1999;14;354–362.

    Article  PubMed  CAS  Google Scholar 

  51. Moore A, Herrera G, etc. Estimated risk of HIV transmission by blood transfusion in Kenya. Lancet, 2001;358:657–660.

    PubMed  CAS  Google Scholar 

  52. UNAIDS and WHO 2000 Global HIV/AIDS and STD Surveillance Epidemiological Factsheets by Country. Available at: http://www.unaids.org/hivaidsinfo/statistics/fact_sheets/index_en.htm. Accessed: January 17, 2002.

  53. Mbanya D, Binam F, Kaptue L. Transfusion outcome in a resource-limited setting of Cameroon: a five-year evaluation. Int J Infect Dis, 2001;5:70–73.

    Article  PubMed  CAS  Google Scholar 

  54. Lackritz EM, Satten GA, Aberle-Grasse J, et al. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N Engl J Med, 1995;333:1721–1725.

    Article  PubMed  CAS  Google Scholar 

  55. Schreiber GB, Busch MP, Kleinman SH, et al. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med, 1996;334:1685–1690.

    PubMed  CAS  Google Scholar 

  56. Lackritz EM. Prevention of HIV transmission by blood transfusion in the developing world: achievements and continuing challenges. AIDS, 1998;12(Suppl A):S81–S86.

    PubMed  Google Scholar 

  57. Gerberding JL, Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: final report from a longitudinal study. J Infect Dis, 1994;170:1410–1417.

    PubMed  CAS  Google Scholar 

  58. Henderson DK, Fahey BJ, Willy M, et al. Risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures. A prospective evaluation. Ann Intern. Med, 1990;113:740–746.

    PubMed  CAS  Google Scholar 

  59. Ippolito G, Puro V, De Carli G. The risk of occupational human immunodeficiency virus infection in health care workers. Italian Multicenter Study. The Italian Study Group on Occupational Risk of HIV infection. Arch Intern Med, 1993;153:1451–1458.

    Article  PubMed  CAS  Google Scholar 

  60. Tokars JI, Marcus R, Culver DH, et al. Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIVinfected blood. The CDC Cooperative Needlestick Surveillance Group. Ann Intern Med, 1993;118:913–919.

    PubMed  CAS  Google Scholar 

  61. Hauri AM, Armstrong G, Hutin Y. Estimation of the global burden of disease attributable to contaminated injections given in health-care settings. Unpublished paper. World Health Organization, 2001.

    Google Scholar 

  62. Hu WS, Temin HM. Retroviral recombination and reverse transcription. Science, 1990;250:1227–1233.

    PubMed  CAS  Google Scholar 

  63. Preston BD, Poiesz BJ, Loeb LA. Fidelity of HIV-1 reverse transcriptase. Science, 1988;242:1168–1171.

    PubMed  CAS  Google Scholar 

  64. Roberts JD, Bebenek K, Kunkel TA. The accuracy of reverse transcriptase from HIV-1. Science, 1988;242:1171–1173.

    PubMed  CAS  Google Scholar 

  65. Ho DD, Neumann AU, Perelson AS, et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature, 1995;373:123–126.

    Article  PubMed  CAS  Google Scholar 

  66. Wei X, Ghosh SK, Taylor ME, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature, 1995;373:117–122.

    Article  PubMed  CAS  Google Scholar 

  67. Alaeus A. Significance of HIV-1 genetic subtypes. Scand J Infect Dis, 2000;32:455–463.

    Article  PubMed  CAS  Google Scholar 

  68. Nowak MA. Variability of HIV infections. J Theor. Biol, 1992;155:1–20.

    PubMed  CAS  Google Scholar 

  69. Peeters M, Gueye A, MBoup S, et al. Geographical distribution of HIV-1 group O viruses in Africa. AIDS, 1997;11:493–498.

    PubMed  CAS  Google Scholar 

  70. Zekeng L, Gurtler L, Afane ZE, et al. Prevalence of HIV-1 subtype O infection in Cameroon: preliminary results. AIDS, 1994;8:1626–1628.

    PubMed  CAS  Google Scholar 

  71. Peeters M, Sharp PM. Genetic diversity of HIV-1: the moving target. AIDS, 2000;14(Suppl 3):S129–S140.

    PubMed  CAS  Google Scholar 

  72. Simon F, Mauclere P, Roques P, et al. Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nat Med, 1998;4:1032–1037.

    PubMed  CAS  Google Scholar 

  73. Gao F, Robertson DL, Morrison SG, et al. The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. J Virol, 1996:70:7013–7029.

    PubMed  CAS  Google Scholar 

  74. Salminen MO, Koch C, Sanders-Buell E, et al. Recovery of virtually full-length HIV-1 provirus of diverse subtypes from primary virus cultures using the polymerase chain reaction. Virology, 1995;213:80–86.

    Article  PubMed  CAS  Google Scholar 

  75. McCutchan FE. Understanding the genetic diversity of HIV-1. AIDS, 2000;14(Suppl 3):S31–S44.

    PubMed  CAS  Google Scholar 

  76. Robertson DL, Anderson JP, Bradac JA, et al. HIV-1 nomenclature proposal. Science, 2000;288:55–56.

    Article  PubMed  CAS  Google Scholar 

  77. Heeney JL, Hahn BH. Vaccines and immunology: elucidating immunity to HIV-1 and current prospects for AIDS vaccine development. AIDS, 2000;14(Suppl 3):S125–S127.

    PubMed  Google Scholar 

  78. Robertson DL, Sharp PM, McCutchan FE, et al. Recombination in HIV-1. Nature, 1995;374:124–126.

    Article  PubMed  CAS  Google Scholar 

  79. Liitsola K, Tashkinova I, Laukkanen T, et al. HIV-1 genetic subtype A/B recombinant strain causing an explosive epidemic in injecting drug users in Kaliningrad. AIDS, 1998;12:1907–1919.

    PubMed  CAS  Google Scholar 

  80. Kaleebu P, Ross A, Morgan D, et al. Relationship between HIV-1 Env subtypes A and D and disease progression in a rural Ugandan cohort. AIDS, 2001;15:293–299.

    PubMed  CAS  Google Scholar 

  81. Janssens W, Buve A, Nkengasong JN. The puzzle of HIV-1 subtypes in Africa. AIDS, 1997;11:705–712.

    Article  PubMed  CAS  Google Scholar 

  82. Blackard JT, Renjifo B, Fawzi W, et al. HIV-1 LTR subtype and perinatal transmission. Virology, 2001;287:261–265.

    Article  PubMed  CAS  Google Scholar 

  83. Tersmette M, Lange JM, de Goede RE, et al. Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality. Lancet, 1989;1: 983–985.

    PubMed  CAS  Google Scholar 

  84. Abebe A, Demissie D, Goudsmit J, et al. HIV-1 subtype C syncytium-and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS. AIDS, 1999;13:1305–1311.

    PubMed  CAS  Google Scholar 

  85. Peeters M, Vincent R, Perret JL, et al. Evidence for differences in MT2 cell tropism according to genetic subtypes of HIV-1: syncytium-inducing variants seem rare among subtype C HIV-1 viruses. J Acquir Immune Defic Syndr Hum Retrovirol, 1999;20:115–121.

    PubMed  CAS  Google Scholar 

  86. Tscherning C, Alaeus A, Fredriksson R, et al. Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. Virology, 1998; 241:181–188.

    Article  PubMed  CAS  Google Scholar 

  87. de Wolf F, Hogervorst E, Goudsmit J, et al. Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. WHO Network for HIV Isolation and Characterization. AIDS Res Hum Retroviruses, 1994;10:1387–1400.

    PubMed  Google Scholar 

  88. Kanki PJ, Hamel DJ, Sankale JL, et al. Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis, 1999; 179:68–73.

    Article  PubMed  CAS  Google Scholar 

  89. Neilson JR, John GC, Carr JK, et al. Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya. J Virol, 1999;73:4393–4403.

    PubMed  CAS  Google Scholar 

  90. Weisman Z, Kalinkovich A, Borkow G, et al. Infection by different HIV-1 subtypes (B and C) results in a similar immune activation profile despite distinct immune backgrounds. J Acquir. Immune Defic Syndr, 1999;21:157–163.

    PubMed  CAS  Google Scholar 

  91. Alaeus A, Lidman K, Bjorkman A, et al. Similar rate of disease progression among individuals infected with HIV-1 genetic subtypes A-D. AIDS, 1999;13:901–907.

    PubMed  CAS  Google Scholar 

  92. Amornkul PN, Tansuphasawadikul S, Limpakarnjanarat K, et al. Clinical disease associated with HIV-1 subtype B’ and E infection among 2104 patients in Thailand. AIDS, 1999;13:1963–1969.

    Article  PubMed  CAS  Google Scholar 

  93. Alaeus A, Lidman K, Sonnerborg A, et al. Subtype-specific problems with quantification of plasma HIV-1 RNA. AIDS, 1997;11:859–865.

    PubMed  CAS  Google Scholar 

  94. Debyser Z, Van Wijngaerden E, Van Laethem K, et al. Failure to quantify viral load with two of the three commercial methods in a pregnant woman harboring an HIV type 1 subtype G strain. AIDS Res Hum Retroviruses, 1998;14:453–459.

    PubMed  CAS  Google Scholar 

  95. Laga M, Nziia N, Goeman J. The interrelationship of sexually transmitted diseases and HIV infection: implications for the control of both epidemics in Africa. AIDS, 1991:5:555–563.

    Google Scholar 

  96. Johnson AM, Laga M. Heterosexual transmission of HIV. AIDS, 1988:2:549–556.

    Google Scholar 

  97. Buve A, Weiss HA, Laga M, et al. Study Group on Heterogeneity of HIV Epidemics in African Cities. The epidemiology of trichomoniasis in women in four African cities. AIDS, 2001;15(Suppl 4):S89–S96.

    PubMed  Google Scholar 

  98. Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomized control trial. Lancet, 1995;346:530–536.

    Article  PubMed  CAS  Google Scholar 

  99. Wawer MJ, Gray RH, Sewankambo NK, et al. A randomized, community-based trial of intense sexually transmitted disease control for AIDS prevention, Rakai, Uganda. AIDS, 1998;12:1211–1225.

    Article  PubMed  CAS  Google Scholar 

  100. Korenromp E. Treatment of sexually transmitted. diseases as an HIV prevention strategy? [Unpublished MD thesis]. 264p. Rotterdam: Erasmus University, 2001.

    Google Scholar 

  101. Cohen MS. Preventing sexual transmission of HIV—new ideas from sub-Saharan Africa. N Engl. J Med, 2000;342:970–972.

    PubMed  CAS  Google Scholar 

  102. UNAIDS & WHO Consultation on STD interventions for preventing HIV: what is the evidence? Geneva, Switzerland: UNAIDS, 2001.

    Google Scholar 

  103. O’Farrell N, Egger M. Circumcision in men and the prevention of HIV infection: a ‘meta-analysis” revisited. Int J STD AIDS, 2000;11:137–142.

    Google Scholar 

  104. Weiss HA, Quigley MA, Hayes RJ. Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. AIDS, 2000;14:2361–2370.

    PubMed  CAS  Google Scholar 

  105. Caraël M, Cleland I, Adeokun L. Overview and selected findings of sexual behavior survevs. AIDS, 1991;5(suppl 1):565–574.

    Google Scholar 

  106. Auvert B, Buve A, Ferry B, et al. Study Group on the Heterogeneity of HIV Epidemics in African Cities. Ecological and individual level analysis of risk factors for HIV infection in four urban populations in sub-Saharan Africa with different levels of HIV infection. AIDS, 2001;15(Suppl 4):S15–S30.

    PubMed  Google Scholar 

  107. Larson A. Social context of human immunodeficiency virus transmission in Africa: historical and cultural bases of east and central African sexual relations. Rev Infect Dis, 1989;11:716–731.

    PubMed  CAS  Google Scholar 

  108. Caraël M., Van de Perre P, Allen S, et al. Sexually active young adults in Central Africa. In: Schinazi RF, Nahmias AJ, eds. AIDS in Children, Adolescents and Heterosexual Adults. New York: Elsevier Science Publishing Co., Inc., 1988:346–349.

    Google Scholar 

  109. Caraël M, Buvé A, Awusabo-Asare K.The Making of HIV epidemics: what are the driving forces? AIDS, 1997;11(B):S23–S31.

    PubMed  Google Scholar 

  110. Morris M, Kretzschmar M. Concurrent partnerships and the spread of HIV AIDS, 1997;11: 641–648.

    Article  PubMed  CAS  Google Scholar 

  111. Temmerman M, All FM, Ndinya-Achola J, et al. Rapid increase of both HIV-1 and syphilis among pregnant women in Nairobi, Kenya. AIDS, 1992;6:1181–1185.

    PubMed  CAS  Google Scholar 

  112. Allen S, Lindan C, Serufllira A, et al. Human immunodeficiency virus infection in urban Rwanda. Demographic and behavioral correlates in a representative sample of childbearing women. JAMA, 1991;266:1657–1663.

    PubMed  CAS  Google Scholar 

  113. Kamenga M, Ryder RW, Jingu M, et al. Evidence of marked sexual behavior change associated with low HIV-1 seroconversion in 149 married couples with discordant HIV-1 serostatus: experiences at an HIV counselling center in Zaire. AIDS, 1991;5:6167.

    Article  Google Scholar 

  114. UNAIDS. Report on the global HIV/AIDS epidemic, June 2000. Geneva, Switzerland: UNAIDS, 2000.

    Google Scholar 

  115. Berkley S, Naamara W, Okware S, et al. AIDS and HIV infection in Uganda: are more women infected than men? AIDS, 1990;4:1237–1242.

    PubMed  CAS  Google Scholar 

  116. Buve A, Carael M, Hayes RJ, et al. Study Group on Heterogeneity of HIV Epidemics in African Cities. The multicentre study on factors determining the differential spread of HIV in four African cities: summary and conclusions. AIDS, 2001;15(Suppl 4):S127–S131.

    PubMed  Google Scholar 

  117. Piot P, Laga M, Ryder R, et al. The global epidemiology of HIV infection: continuity, heterogeneity, and change. J Acquir Immune Defic Syndr, 1990;3:403–412.

    PubMed  CAS  Google Scholar 

  118. Glynn JR, Ponnighaus J, Crampin AC, et al. The development of the HIV epidemic in Karonga District, Malawi. AIDS, 2001;15:2025–2029.

    PubMed  CAS  Google Scholar 

  119. Fylkesnes K, Musonda RM, Sichone M, et al. Declining HIV prevalence and risk behaviours in Zambia: evidence from surveillance and population-based surveys. AIDS, 2001;15:907–916.

    PubMed  CAS  Google Scholar 

  120. Ryder RW, Ndilu M, Hassig SE, et al. Heterosexual transmission of HIV-1 among employees and their spouses at two large businesses in Zaire. AIDS, 1990;4:725–732.

    PubMed  CAS  Google Scholar 

  121. Melbye M, Njelesani EK, Bayley A, et al. Evidence for heterosexual transmission and clinical manifestations of human immunodeficiency virus infection and related conditions in Lusaka, Zambia. Lancet, 1986;3:1113–1115.

    Google Scholar 

  122. BIDPA. Macroeconomic Impacts of the HIV/AIDS Epidemic in Botswana. Gaborone: Botswana Institute for Development Policy Analysis, 2000.

    Google Scholar 

  123. Food and Agriculture Organisation Web site. Focus: AIDS, A Threat to Africa. Available at: http://www.fao.org/FOCUS/E/aids/aids1-e.htm. Accessed: January 18, 2002.

  124. Lamptey P, Goodridge GAW. Condom issues in AIDS prevention in Africa. AIDS, 1991;5(suppl 1):S183–S191.

    PubMed  Google Scholar 

  125. Tuliza M, Manoka AT, Nzila N, et al. The impact of STD control and condom promotion on the incidence of HIV in Kinshasa prostitutes. In: Abstracts of the VII International Conference on AIDS; June 1991; Florence, Italy. Abstract MC2.

    Google Scholar 

  126. Moses S, Plummer FA, Ngugi EN, et al. Controlling HIV in Africa: effectiveness and cost of an intervention in a high-frequency STD transmitter core group. AIDS, 1991;5:407–411.

    PubMed  CAS  Google Scholar 

  127. Jordan-Harder B, Koshuma YA, Pervilhac C, et al. Hope for Tanzania: Lessons Learned from a Decade of Comprehensive AIDS Control in Mbeya Region. Eschborn, Germany: GTZ and Dar-es-Salaam: Ministry of Health, United Republic of Tanzania, 2000.

    Google Scholar 

  128. Kamali A, Carpenter L, Whitworth J, et al. Sevenyear trends in HIV-1 infection rates, and changes in sexual behaviour, among adults in rural Uganda. AIDS, 2000;14:427–434.

    PubMed  CAS  Google Scholar 

  129. Perriens SH, Mukadi Y, Nunn P. Tuberculosis and HIV infection: implications for Africa. AIDS, 1991;5(suppl I):5127–5133.

    Google Scholar 

  130. Styblo K. Overview and epidemiological assessment of the current global tuberculosis situation with an emphasis on control in developing countries. Rev Infect Dis, 1989;11(suppl 2):S339–S346.

    PubMed  Google Scholar 

  131. Standaert B, Niragira F, Kadende P, et al. The association of tuberculosis and HIV infection in Burundi. AIDS Res Hum Retroviruses, 1989:5:247–251.

    Article  PubMed  CAS  Google Scholar 

  132. Lesbordes IL, Baqillon G, Georges MC, et al. La tuberculose au cours de l’infection par le virus de l’immunodéficience hutnaine à Bangui (République Centrafricaine). Méd Trop, 1988;48:21–25.

    CAS  Google Scholar 

  133. Badi N, Braun M, Ryder R, et al. A retrospective cohort study of the incidence of tuberculosis (TB) among child-bearing women with HIV infection in Kinshasa, Zaire. In: Abstracts of the VI International Conference on AIDS; June 1990; San Francisco, California, USA. Abstract ThB485.

    Google Scholar 

  134. Wadhawan D, Hira S, Mwanza N, et al. Isoniazid prophylaxis among patients with HIV-I infection. Abstracts of the VI International Conference on AIDS; June 1990; San Francisco, California, USA. Abstract ThB510.

    Google Scholar 

  135. Batungwanayo I, Allen S, Bogaerts J, et al. Etude prospective du risque de tuberculose dans une cohorte de femmes VIH seropositives ∼ Kigali, Rwanda. In: Abstracts of the V International Conference on AIDS in Africa; October 1990; Kinshasa, Zaire. Abstract WOD4.

    Google Scholar 

  136. Perriens JH, Colebunders R, Karahunga C, et al. Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive patients compared with HIV seronegative patients with pulmonary tuberculosis treated with “standard“ chemotherapy in Kinshasa, Zaire. Am Rev Respir Dis, 1991;144:750–755.

    PubMed  CAS  Google Scholar 

  137. Nunn P, Kibuga D, Elliott A, et al. Impact of human immunodeficiency virus on transmission and severity of tuberculosis. Transact Roy Soc Trop Med Hyg, 1990;84(suppl 1):9–13.

    Google Scholar 

  138. Girardi E, Goletti D, Antonucci G, et al. Tuberculosis and HIV: a deadly interaction. J Biol Regul Homeost Agents, 2001;15:218–223.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Joint United Nations Programme on HIV/AID, Geneva, Switzerland

    Peter Piot & Michael Bartos

Authors
  1. Peter Piot
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael Bartos
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Harvard AIDS Institute Mary Woodard Lasker Professor of Health Sciences Harvard University, Boston, Massachusetts, USA

    Max Essex DVM, PhD (Chairman) & Richard G. Marlink MD (Senior Research and Executive Director) (Chairman) &  (Senior Research and Executive Director)

  2. Laboratory of Bacteriology and Virology CHU Le Dantec, Université Cheikh Anta Diop, Dakar, Senegal

    Souleymane Mboup PharmD, PhD (Professor of Microbiology) (Professor of Microbiology)

  3. Department of Immunology and Infectious Diseases and the Harvard AIDS Institute, Harvard School of Public Health, Boston, Massachusetts, USA

    Phyllis J. Kanki DVM, DSc (Professor of Immunology and Infectious Diseases) & Molly Holme (Professor of Immunology and Infectious Diseases) & 

  4. Department of Nursing Education University of Botswana, Gaborone, Botswana

    Sheila D. Tlou PhD (Associate Professor) (Associate Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Kluwer Academic Publishers

About this chapter

Cite this chapter

Piot, P., Bartos, M. (2002). The Epidemiology of HIV and AIDS. In: Essex, M., Mboup, S., Kanki, P.J., Marlink, R.G., Tlou, S.D., Holme, M. (eds) AIDS in Africa. Springer, Boston, MA. https://doi.org/10.1007/0-306-47817-X_12

Download citation

  • DOI: https://doi.org/10.1007/0-306-47817-X_12

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-46699-1

  • Online ISBN: 978-0-306-47817-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation